IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM NEW
Total 13F shares
34,519,029
Share change
-6,686,941
Total reported value
$52,835,738
Put/Call ratio
66%
Price per share
$1.53
Number of holders
73
Value change
-$13,199,878
Number of buys
29
Number of sells
23

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q2 2016

As of 30 Jun 2016, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,519,029 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, JPMORGAN CHASE & CO, NATIXIS, Broadfin Capital, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, Palo Alto Investors, LLC, and NORTHERN TRUST CORP. This page lists 73 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.